Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 89372 · Class III · Vitalant
Key facts
| Event ID | 89372 |
|---|---|
| Recall numbers | B-0198-2022 |
| Recalling firm | Vitalant |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Red Blood Cells, in which the donor's hemoglobin was documented non-concurrently, was distributed. |
| Initiation date | Nov 18, 2021 |
| Report date | Feb 9, 2022 |
| Termination date | Jan 28, 2022 |
| City | El Paso |
| State | TX |
| Country | United States |
| FEI number | 1671451 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: